Strong Signs for a Weak Wall in Tricuspid Aortic Valve Associated Aneurysms and a Role for Osteopontin in Bicuspid Aortic Valve Associated Aneurysms.
Christian SternBernhard ScharingerAdrian TuerkcanClemens NebertTeresa MimlerUlrike BaranyiChristian DopplerThomas AschacherMartin AndreasMarie-Elisabeth StelzmuellerMarek EhrlichAlexandra GrafGuenther LauferDavid BernhardBarbara MessnerPublished in: International journal of molecular sciences (2019)
Central processes in the pathogenesis of TAV- (tricuspid aortic valve) and BAV- (bicuspid aortic valve) associated ascending thoracic aortic aneurysm (ATAA) development are still unknown. To gain new insights, we have collected aortic tissue and isolated smooth muscle cells of aneurysmal tissue and subjected them to in situ and in vitro analyses. We analyzed aortic tissue from 78 patients (31 controls, 28 TAV-ATAAs, and 19 BAV-ATAAs) and established 30 primary smooth muscle cell cultures. Analyses included histochemistry, immuno-, auto-fluorescence-based image analyses, and cellular analyses including smooth muscle cell contraction studies. With regard to TAV associated aneurysms, we observed a strong impairment of the vascular wall, which appears on different levels-structure and dimension of the layers (reduced media thickness, increased intima thickness, atherosclerotic changes, degeneration of aortic media, decrease of collagen, and increase of elastic fiber free area) as well as on the cellular level (accumulation of fibroblasts/myofibroblasts, and increase in the number of smooth muscle cells with a reduced alpha smooth muscle actin (α-SM actin) content per cell). The pathological changes in the aortic wall of BAV patients were much less pronounced-apart from an increased expression of osteopontin (OPN) in the vascular wall which stem from smooth muscle cells, we observed a trend towards increased calcification of the aortic wall (increase significantly associated with age). These observations provide strong evidence for different pathological processes and different disease mechanisms to occur in BAV- and TAV-associated aneurysms.
Keyphrases
- aortic valve
- smooth muscle
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- ejection fraction
- end stage renal disease
- newly diagnosed
- single cell
- cell therapy
- prognostic factors
- spinal cord
- heart failure
- cardiovascular disease
- optical coherence tomography
- spinal cord injury
- mesenchymal stem cells
- stem cells
- aortic aneurysm
- deep learning
- pulmonary arterial hypertension
- coronary artery
- atrial fibrillation